About Consern
Consern is a Healthcare company based in India founded in 2016. Consern is an RD company focused on manufacturing drugs for various therapeutic areas. It operates on a B2B model. The company has 504 employees. Its Indian entity Consern Pharma Limited reported revenue of ₹100 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and R&D and Therapeutics.
Company details
Consern operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and rd and therapeutics. Consern is an RD company focused on manufacturing drugs for various therapeutic areas. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters India
- Employees 504
- SectorsHealthcare
- Website consern.in/index.php
- Social X Facebook
- Legal Name Consern Pharma Limited
- Date of Incorporation 17 Oct, 2001
- Jurisdiction Ludhiana, Punjab, India
- Annual Revenue₹100 Cr
FY 2025 · -2% YoY
- Net Profit₹9.64 Cr
FY 2025 · 10% margin
- EBITDA₹15.10 Cr
FY 2025 · 15% margin
- Employee Count504
Associated legal entities of Consern
Consern operates through Consern Pharma Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Consern Pharma Limited CIN U24232PB2001PLC024715 | Active | 17 Oct 2001 | Ludhiana, Punjab | ₹100 Cr | 504 | 5 | View details |
Board of directors of Consern Pharma Limited (Consern)
Consern Pharma Limited is the primary company behind Consern. The board of Consern Pharma Limited currently have 5 directors; the longest-serving is Seema Mahajan, appointed in 2001. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Seema Mahajan DIN 00605605 | Whole-time director | 17 Oct 2001 | 24 yrs 11 mo | Consern Pharma Limited |
| Kuljive Mahajan DIN 00603252 | Managing Director | 01 Apr 2004 | 22 yrs 6 mo | Consern Pharma Limited |
| Atul Bhatara DIN 08847114 | Director | 01 Oct 2024 | 2 yrs | Consern Pharma Limited |
| Riaz K Mahajan DIN 11085295 | Additional Director | 01 Jun 2025 | 1 yr 4 mo | Consern Pharma Limited |
| Suresh Goel DIN 00478373 | Additional Director | 01 Sep 2025 | 1 yr 1 mo | Consern Pharma Limited |
Financials of Consern
Figures of Consern Pharma Limited, the primary company behind Consern, for FY 2025. Revenue was ₹100 Cr (-2% year on year). Net profit was ₹9.64 Cr (10% margin). EBITDA was ₹15.10 Cr (15% margin). Revenue has grown at a compounded annual rate of +19% over three years and +17% over five years.
- ₹100 CrRevenue · FY 2025 · -2% YoY
- ₹9.64 CrNet profit · 10% margin
- ₹15.10 CrEBITDA · 15% margin
- ₹30.8 LakhPaid-up capital
- 504Employees (provident fund records)
- +19%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Consern Pharma Limited are on its company page.
Detailed financial statements for Consern
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Consern (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Consern
Consern was founded in 2016.
Consern is headquartered in India.
Consern has 504 employees.
The primary company behind Consern, Consern Pharma Limited, reported revenue of ₹100 Cr for FY 2025, down 2% year on year.
Consern operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and rd and therapeutics. Consern is an RD company focused on manufacturing drugs for various therapeutic areas. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Consern operates through Consern Pharma Limited.
The legal entities of Consern currently have 5 directors, including Seema Mahajan, Kuljive Mahajan, Riaz K Mahajan and others.